Related Experiment Video
Updated: Mar 23, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.8K
What Is the Malignancy Risk in Neurofibromatosis Type 1?
1St Mary's Hospital, Central Manchester Hospitals Foundation Trust, Manchester, United Kingdom gareth.evans@cmft.nhs.uk.
Abstract
No abstract available in PubMed .

